| 337 |
309: Reduction, Vitellogenin accumulation into oocytes and oocyte growth/development |
78: Reduction, Cumulative fecundity and spawning |
Nov 29, 2016 |
Mar 20, 2017 |
9 AOPs
|
| 3396 |
309: Reduction, Vitellogenin accumulation into oocytes and oocyte growth/development |
1467: Growth, reduction |
Nov 16, 2024 |
Nov 16, 2024 |
1 AOP
|
| 315 |
285: Reduction, Vitellogenin synthesis in liver |
221: Reduction, Plasma vitellogenin concentrations |
Nov 29, 2016 |
Mar 20, 2017 |
7 AOPs
|
| 1081 |
1040: relaxation, smooth muscle |
1042: Proliferation/Clonal Expansion, smooth muscle |
Nov 29, 2016 |
Dec 3, 2016 |
1 AOP
|
| 1564 |
1426: Release of G Proteins |
1427: Opening of GIRK channels |
Jun 8, 2017 |
Jun 8, 2017 |
2 AOPs
|
| 1568 |
1426: Release of G Proteins |
1429: Inhibition of Ca Channels |
Jun 23, 2017 |
Jun 23, 2017 |
2 AOPs
|
| 108 |
87: Release, Cytokine |
149: Increase, Inflammation |
Nov 29, 2016 |
Dec 3, 2016 |
1 AOP
|
| 925 |
87: Release, Cytokine |
907: Infiltration, Inflammatory cytokines |
Nov 29, 2016 |
Dec 3, 2016 |
None
|
| 994 |
87: Release, Cytokine |
901: Infiltration, Inflammatory cells |
Nov 29, 2016 |
Nov 29, 2016 |
None
|
| 1963 |
87: Release, Cytokine |
1497: Recruitment of inflammatory cells |
Jul 3, 2019 |
Jul 3, 2019 |
2 AOPs
|
| 2454 |
87: Release, Cytokine |
1914: Platelet activation, Increased |
Aug 4, 2021 |
Aug 4, 2021 |
1 AOP
|
| 2455 |
87: Release, Cytokine |
1915: Neutrophil activation, Increased |
Aug 4, 2021 |
Aug 4, 2021 |
1 AOP
|
| 1648 |
495: Repressed expression of steroidogenic enzymes |
413: Reduction, Testosterone synthesis in Leydig cells |
Aug 11, 2017 |
Aug 11, 2017 |
1 AOP
|
| 3615 |
495: Repressed expression of steroidogenic enzymes |
1690: Decrease, circulating testosterone levels |
Sep 3, 2025 |
Sep 3, 2025 |
1 AOP
|
| 3623 |
495: Repressed expression of steroidogenic enzymes |
3: Reduction, 17beta-estradiol synthesis by ovarian granulosa cells |
Sep 3, 2025 |
Sep 3, 2025 |
None
|
| 2436 |
1902: Repression of Gbx2 expression |
1903: foxi1 expression, increased |
Jul 14, 2021 |
Aug 13, 2021 |
1 AOP
|
| 433 |
445: Respiratory distress/arrest |
351: Increased Mortality |
Nov 29, 2016 |
Dec 20, 2019 |
1 AOP
|
| 592 |
445: Respiratory distress/arrest |
590: N/A, hypoxia |
Nov 29, 2016 |
Dec 3, 2016 |
1 AOP
|
| 378 |
397: Response, Keratinocytes |
398: Activation, Dendritic Cells |
Nov 29, 2016 |
Nov 29, 2016 |
None
|
| 380 |
397: Response, Keratinocytes |
272: Activation/Proliferation, T-cells |
Nov 29, 2016 |
Dec 3, 2016 |
None
|
| 1915 |
1637: Retinaldehyde dehydrogenase |
1641: retinoic acid |
May 22, 2019 |
May 22, 2019 |
1 AOP
|
| 3036 |
2186: Activation, RyR |
1350: Increased, glutamate |
Sep 8, 2023 |
Sep 8, 2023 |
1 AOP
|
| 2052 |
1738: SARS-CoV-2 cell entry |
1496: Increased proinflammatory mediators |
Mar 1, 2020 |
Mar 1, 2020 |
None
|
| 2302 |
1738: SARS-CoV-2 cell entry |
1848: TLR Activation/Dysregulation |
Mar 29, 2021 |
Mar 29, 2021 |
None
|
| 2310 |
1738: SARS-CoV-2 cell entry |
1847: SARS-CoV-2 production |
Mar 30, 2021 |
Feb 7, 2023 |
2 AOPs
|